Paul Tebbey
Geschäftsführer bei Elusys Therapeutics, Inc.
Profil
Paul W.
Tebbey is currently the Director at Radyus Research, Inc. and the Chief Operating Officer at Elusys Therapeutics, Inc. Previously, he held the position of Senior VP-Product Development & Portfolio Strategy at Scorpius Holdings, Inc. from 2021 to 2023.
He holds a doctorate degree from East Carolina University and an MBA from Rochester Institute of Technology.
Aktive Positionen von Paul Tebbey
| Unternehmen | Position | Beginn |
|---|---|---|
Radyus Research, Inc.
 Radyus Research, Inc. Medical/Nursing ServicesHealth Services Radyus Research, Inc. provides healthcare services. The company is headquartered in Atlanta, GA. | Direktor/Vorstandsmitglied | - |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Geschäftsführer | - |
Ehemalige bekannte Positionen von Paul Tebbey
| Unternehmen | Position | Ende |
|---|---|---|
| SCORPIUS HOLDINGS, INC. | Corporate Officer/Principal | 01.01.2023 |
Ausbildung von Paul Tebbey
| East Carolina University | Doctorate Degree |
| Rochester Institute of Technology | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SCORPIUS HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Health Technology |
Radyus Research, Inc.
Radyus Research, Inc. Medical/Nursing ServicesHealth Services Radyus Research, Inc. provides healthcare services. The company is headquartered in Atlanta, GA. | Health Services |
